Last reviewed · How we verify
NCT03946631
GDM Post Partum Screening
trial testing 2 hour glucose tolerance test using 75g glucose drink in Diabetes in 21 participants. Terminated before completion.
21 October 2022
Quick facts
| Lead sponsor | Pediatrix |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 21 |
| Start date | 20 August 2019 |
| Primary completion | 21 October 2022 |
| Estimated completion | 21 October 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 2 hour glucose tolerance test using 75g glucose drink
Conditions studied
- Diabetes — all drugs for Diabetes →
- Gestational Diabetes — all drugs for Gestational Diabetes →
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
Pediatrix — full company profile →
Who can join
Adults 18 to 60, female only, with Diabetes or Gestational Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Immediate postpartum screening for diabetes mellitus in women with gestational diabetes The objective of this study is to determine if screening for type 2 diabetes can be done 24 hours after delivery, versus 6-12 weeks postpartum, in recently delivered women having been diagnosed with gestational diabetes requiring medication therapy in the antecedent pregnancy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03946631
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Pediatrix trials
Trials by the same sponsor.
- NCT04977817 — Probiotics/TPN in the NICU · completed
- NCT04971694 — Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes · completed
- NCT04513691 — A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the · completed
- NCT04085978 — Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission · terminated
- NCT03414671 — The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Length of Stay · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03946631 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pediatrix
- Last refreshed: 14 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03946631.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing